EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CAR-T therapy in non-small cell lung cancer: Clinical prospects, potential, and strategies for cardiotoxicity management

Yihao Liu, Yizhu Gao, Chenyu Huo, Tao Zeng, Wenjun Meng, Haoling Zhang, Qinqin He

Translational Oncology · 2026-02 · 64 · 102662

DOI: 10.1016/j.tranon.2025.102662 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Oncology, 2026-02. Verfasst von Yihao Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pain Management, West China Hospital, Sichuan University, Chengdu, China; Department of Lung Cancer Surgery, Tianjin Medical University…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Program of Gansu Province, Science and Technology Department of Gansu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer ranks first among all malignancies in incidence, with current treatment strategies including surgery, chemotherapy, immunotherapy, and targeted therapy. Despite these advances, drug resistance in advanced non-small cell lung cancer (NSCLC) remains a major obstacle and innovative therapeutic approaches are imperative to address it. Chimeric antigen receptor T-cell (CAR-T) therapy has shown impressive and long-lasting results in blood cancers, but its success in solid tumors such as lung cancer remains limited. This review summarizes recent advances and future directions of CAR-T therapy in NSCLC, focusing on major therapeutic targets such as EGFR, MSLN, PD-L1, MUC1, CEA, and ROR1, as well as on the efficacy and potential of combining CAR-T therapy with other treatment modalities. Additionally, we discuss adverse events in NSCLC patients undergoing CAR-T therapy, emphasizing cytokine release syndrome (CRS) and cardiovascular complications-their incidence, pathophysiology, interrelation, and management strategies.

Schlagwörter

Stichwörter der Autor:innen

CAR-TCancer immunologyCardio-ImmunologyCardiotoxicityCytokine release syndrome (CRS)Immune evasionImmunotherapyNSCLC

Autor:innen und Institutionen

  • Department of Pain Management, West China Hospital, Sichuan University, Chengdu, China; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Department of Emergency Medicine, West China Hospital, Sichuan University, Chengdu, China.
  • Division of Clinical Immunology and Cancer Immunotherapy, Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.
  • Department of Pain Management, West China Hospital, Sichuan University, Chengdu, China. Electronic address: mwj1995@scu.edu.cn.
  • Department of Biomedical Sciences, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Kepala Batas, Penang, Malaysia. Electronic address: zhanghaolingedu@163.com.

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Program of Gansu Province
  • Science and Technology Department of Gansu Province
  • Natural Science Foundation of Sichuan Province

Zitieren

APA

Liu, Y., Gao, Y., Huo, C., Zeng, T., Meng, W., Zhang, H., & He, Q. (2026). CAR-T therapy in non-small cell lung cancer: Clinical prospects, potential, and strategies for cardiotoxicity management. Translational Oncology, 64, 102662. https://doi.org/10.1016/j.tranon.2025.102662

Vancouver

Liu Y, Gao Y, Huo C, Zeng T, Meng W, Zhang H, et al. CAR-T therapy in non-small cell lung cancer: Clinical prospects, potential, and strategies for cardiotoxicity management. Translational Oncology. 2026;64:102662. doi:10.1016/j.tranon.2025.102662

BibTeX
@article{Liu2026,
  author = {Liu, Yihao and Gao, Yizhu and Huo, Chenyu and Zeng, Tao and Meng, Wenjun and Zhang, Haoling and He, Qinqin},
  title = {CAR-T therapy in non-small cell lung cancer: Clinical prospects, potential, and strategies for cardiotoxicity management},
  journal = {Translational Oncology},
  year = {2026},
  volume = {64},
  pages = {102662},
  doi = {10.1016/j.tranon.2025.102662}
}
Kostenlos starten →